Characterization of the 1918 "Spanish" influenza virus matrix gene segment.
Identifieur interne : 000653 ( Main/Exploration ); précédent : 000652; suivant : 000654Characterization of the 1918 "Spanish" influenza virus matrix gene segment.
Auteurs : Ann H. Reid [États-Unis] ; Thomas G. Fanning ; Thomas A. Janczewski ; Sherman Mccall ; Jeffery K. TaubenbergerSource :
- Journal of virology [ 0022-538X ] ; 2002.
Descripteurs français
- KwdFr :
- Amantadine (pharmacologie), Analyse de séquence d'ADN (MeSH), Antiviraux (pharmacologie), Données de séquences moléculaires (MeSH), Espagne (MeSH), Gènes viraux (MeSH), Humains (MeSH), Phylogenèse (MeSH), Protéines de la matrice virale (génétique), Résistance virale aux médicaments (MeSH), Séquence nucléotidique (MeSH), Virus de la grippe A (classification), Virus de la grippe A (effets des médicaments et des substances chimiques), Virus de la grippe A (génétique), Virus de la grippe A (isolement et purification).
- MESH :
- effets des médicaments et des substances chimiques : Virus de la grippe A.
- génétique : Protéines de la matrice virale, Virus de la grippe A.
- isolement et purification : Virus de la grippe A.
- pharmacologie : Amantadine, Antiviraux.
- Analyse de séquence d'ADN, Données de séquences moléculaires, Espagne, Gènes viraux, Humains, Phylogenèse, Résistance virale aux médicaments, Séquence nucléotidique.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Amantadine (pharmacology), Antiviral Agents (pharmacology), Base Sequence (MeSH), Drug Resistance, Viral (MeSH), Genes, Viral (MeSH), Humans (MeSH), Influenza A virus (classification), Influenza A virus (drug effects), Influenza A virus (genetics), Influenza A virus (isolation & purification), Molecular Sequence Data (MeSH), Phylogeny (MeSH), Sequence Analysis, DNA (MeSH), Spain (MeSH), Viral Matrix Proteins (genetics).
- MESH :
- chemical , genetics : Viral Matrix Proteins.
- chemical , pharmacology : Amantadine, Antiviral Agents.
- geographic : Spain.
- classification : Influenza A virus.
- drug effects : Influenza A virus.
- genetics : Influenza A virus.
- isolation & purification : Influenza A virus.
- Base Sequence, Drug Resistance, Viral, Genes, Viral, Humans, Molecular Sequence Data, Phylogeny, Sequence Analysis, DNA.
Abstract
The coding region of influenza A virus RNA segment 7 from the 1918 pandemic virus, consisting of the open reading frames of the two matrix genes M1 and M2, has been sequenced. While this segment is highly conserved among influenza virus strains, the 1918 sequence does not match any previously sequenced influenza virus strains. The 1918 sequence matches the consensus over the M1 RNA-binding domains and nuclear localization signal and the highly conserved transmembrane domain of M2. Amino acid changes that correlate with high yield and pathogenicity in animal models were not found in the 1918 strain. Phylogenetic analyses suggest that both genes were mammalian adapted and that the 1918 sequence is very similar to the common ancestor of all subsequent human and classical swine matrix segments. The 1918 sequence matches other mammalian strains at 4 amino acids in the extracellular domain of M2 that differ consistently between avian and mammalian strains, suggesting that the matrix segment may have been circulating in human strains for at least several years before 1918.
DOI: 10.1128/jvi.76.21.10717-10723.2002
PubMed: 12368314
PubMed Central: PMC136643
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Characterization of the 1918 "Spanish" influenza virus matrix gene segment.</title><author><name sortKey="Reid, Ann H" sort="Reid, Ann H" uniqKey="Reid A" first="Ann H" last="Reid">Ann H. Reid</name><affiliation wicri:level="1"><nlm:affiliation>Division of Molecular Pathology, Department of Cellular Pathology and Genetics, Armed Forces Institute of Pathology, Rockville, Maryland 20850-3125, USA. Reid@afip.osd.mil</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Molecular Pathology, Department of Cellular Pathology and Genetics, Armed Forces Institute of Pathology, Rockville, Maryland 20850-3125</wicri:regionArea><wicri:noRegion>Maryland 20850-3125</wicri:noRegion></affiliation></author><author><name sortKey="Fanning, Thomas G" sort="Fanning, Thomas G" uniqKey="Fanning T" first="Thomas G" last="Fanning">Thomas G. Fanning</name></author><author><name sortKey="Janczewski, Thomas A" sort="Janczewski, Thomas A" uniqKey="Janczewski T" first="Thomas A" last="Janczewski">Thomas A. Janczewski</name></author><author><name sortKey="Mccall, Sherman" sort="Mccall, Sherman" uniqKey="Mccall S" first="Sherman" last="Mccall">Sherman Mccall</name></author><author><name sortKey="Taubenberger, Jeffery K" sort="Taubenberger, Jeffery K" uniqKey="Taubenberger J" first="Jeffery K" last="Taubenberger">Jeffery K. Taubenberger</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2002">2002</date><idno type="RBID">pubmed:12368314</idno><idno type="pmid">12368314</idno><idno type="pmc">PMC136643</idno><idno type="doi">10.1128/jvi.76.21.10717-10723.2002</idno><idno type="wicri:Area/Main/Corpus">00647</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00647</idno><idno type="wicri:Area/Main/Curation">000647</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000647</idno><idno type="wicri:Area/Main/Exploration">000647</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Characterization of the 1918 "Spanish" influenza virus matrix gene segment.</title><author><name sortKey="Reid, Ann H" sort="Reid, Ann H" uniqKey="Reid A" first="Ann H" last="Reid">Ann H. Reid</name><affiliation wicri:level="1"><nlm:affiliation>Division of Molecular Pathology, Department of Cellular Pathology and Genetics, Armed Forces Institute of Pathology, Rockville, Maryland 20850-3125, USA. Reid@afip.osd.mil</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Molecular Pathology, Department of Cellular Pathology and Genetics, Armed Forces Institute of Pathology, Rockville, Maryland 20850-3125</wicri:regionArea><wicri:noRegion>Maryland 20850-3125</wicri:noRegion></affiliation></author><author><name sortKey="Fanning, Thomas G" sort="Fanning, Thomas G" uniqKey="Fanning T" first="Thomas G" last="Fanning">Thomas G. Fanning</name></author><author><name sortKey="Janczewski, Thomas A" sort="Janczewski, Thomas A" uniqKey="Janczewski T" first="Thomas A" last="Janczewski">Thomas A. Janczewski</name></author><author><name sortKey="Mccall, Sherman" sort="Mccall, Sherman" uniqKey="Mccall S" first="Sherman" last="Mccall">Sherman Mccall</name></author><author><name sortKey="Taubenberger, Jeffery K" sort="Taubenberger, Jeffery K" uniqKey="Taubenberger J" first="Jeffery K" last="Taubenberger">Jeffery K. Taubenberger</name></author></analytic><series><title level="j">Journal of virology</title><idno type="ISSN">0022-538X</idno><imprint><date when="2002" type="published">2002</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amantadine (pharmacology)</term><term>Antiviral Agents (pharmacology)</term><term>Base Sequence (MeSH)</term><term>Drug Resistance, Viral (MeSH)</term><term>Genes, Viral (MeSH)</term><term>Humans (MeSH)</term><term>Influenza A virus (classification)</term><term>Influenza A virus (drug effects)</term><term>Influenza A virus (genetics)</term><term>Influenza A virus (isolation & purification)</term><term>Molecular Sequence Data (MeSH)</term><term>Phylogeny (MeSH)</term><term>Sequence Analysis, DNA (MeSH)</term><term>Spain (MeSH)</term><term>Viral Matrix Proteins (genetics)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Amantadine (pharmacologie)</term><term>Analyse de séquence d'ADN (MeSH)</term><term>Antiviraux (pharmacologie)</term><term>Données de séquences moléculaires (MeSH)</term><term>Espagne (MeSH)</term><term>Gènes viraux (MeSH)</term><term>Humains (MeSH)</term><term>Phylogenèse (MeSH)</term><term>Protéines de la matrice virale (génétique)</term><term>Résistance virale aux médicaments (MeSH)</term><term>Séquence nucléotidique (MeSH)</term><term>Virus de la grippe A (classification)</term><term>Virus de la grippe A (effets des médicaments et des substances chimiques)</term><term>Virus de la grippe A (génétique)</term><term>Virus de la grippe A (isolement et purification)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Viral Matrix Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Amantadine</term><term>Antiviral Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Protéines de la matrice virale</term><term>Virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Amantadine</term><term>Antiviraux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Base Sequence</term><term>Drug Resistance, Viral</term><term>Genes, Viral</term><term>Humans</term><term>Molecular Sequence Data</term><term>Phylogeny</term><term>Sequence Analysis, DNA</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Analyse de séquence d'ADN</term><term>Données de séquences moléculaires</term><term>Espagne</term><term>Gènes viraux</term><term>Humains</term><term>Phylogenèse</term><term>Résistance virale aux médicaments</term><term>Séquence nucléotidique</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The coding region of influenza A virus RNA segment 7 from the 1918 pandemic virus, consisting of the open reading frames of the two matrix genes M1 and M2, has been sequenced. While this segment is highly conserved among influenza virus strains, the 1918 sequence does not match any previously sequenced influenza virus strains. The 1918 sequence matches the consensus over the M1 RNA-binding domains and nuclear localization signal and the highly conserved transmembrane domain of M2. Amino acid changes that correlate with high yield and pathogenicity in animal models were not found in the 1918 strain. Phylogenetic analyses suggest that both genes were mammalian adapted and that the 1918 sequence is very similar to the common ancestor of all subsequent human and classical swine matrix segments. The 1918 sequence matches other mammalian strains at 4 amino acids in the extracellular domain of M2 that differ consistently between avian and mammalian strains, suggesting that the matrix segment may have been circulating in human strains for at least several years before 1918.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12368314</PMID><DateCompleted><Year>2002</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN><JournalIssue CitedMedium="Print"><Volume>76</Volume><Issue>21</Issue><PubDate><Year>2002</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J. Virol.</ISOAbbreviation></Journal><ArticleTitle>Characterization of the 1918 "Spanish" influenza virus matrix gene segment.</ArticleTitle><Pagination><MedlinePgn>10717-23</MedlinePgn></Pagination><Abstract><AbstractText>The coding region of influenza A virus RNA segment 7 from the 1918 pandemic virus, consisting of the open reading frames of the two matrix genes M1 and M2, has been sequenced. While this segment is highly conserved among influenza virus strains, the 1918 sequence does not match any previously sequenced influenza virus strains. The 1918 sequence matches the consensus over the M1 RNA-binding domains and nuclear localization signal and the highly conserved transmembrane domain of M2. Amino acid changes that correlate with high yield and pathogenicity in animal models were not found in the 1918 strain. Phylogenetic analyses suggest that both genes were mammalian adapted and that the 1918 sequence is very similar to the common ancestor of all subsequent human and classical swine matrix segments. The 1918 sequence matches other mammalian strains at 4 amino acids in the extracellular domain of M2 that differ consistently between avian and mammalian strains, suggesting that the matrix segment may have been circulating in human strains for at least several years before 1918.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reid</LastName><ForeName>Ann H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Division of Molecular Pathology, Department of Cellular Pathology and Genetics, Armed Forces Institute of Pathology, Rockville, Maryland 20850-3125, USA. Reid@afip.osd.mil</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fanning</LastName><ForeName>Thomas G</ForeName><Initials>TG</Initials></Author><Author ValidYN="Y"><LastName>Janczewski</LastName><ForeName>Thomas A</ForeName><Initials>TA</Initials></Author><Author ValidYN="Y"><LastName>McCall</LastName><ForeName>Sherman</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Taubenberger</LastName><ForeName>Jeffery K</ForeName><Initials>JK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C031540">M-protein, influenza virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C488936">M1 protein, Influenza A virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C488937">M2 protein, Influenza A virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014763">Viral Matrix Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>BF4C9Z1J53</RegistryNumber><NameOfSubstance UI="D000547">Amantadine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000547" MajorTopicYN="N">Amantadine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005814" MajorTopicYN="N">Genes, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014763" MajorTopicYN="N">Viral Matrix Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>10</Month><Day>9</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>11</Month><Day>28</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>10</Month><Day>9</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12368314</ArticleId><ArticleId IdType="pmc">PMC136643</ArticleId><ArticleId IdType="doi">10.1128/jvi.76.21.10717-10723.2002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nat Struct Biol. 1997 Mar;4(3):239-44</Citation><ArticleIdList><ArticleId IdType="pubmed">9164466</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1989 Nov 11;17(21):8569-80</Citation><ArticleIdList><ArticleId IdType="pubmed">2479906</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1991 Oct 4;67(1):117-30</Citation><ArticleIdList><ArticleId IdType="pubmed">1913813</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull Hist Med. 2002 Spring;76(1):105-15</Citation><ArticleIdList><ArticleId IdType="pubmed">11875246</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1992 Sep;190(1):11-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1529523</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 1996 Oct;44(2):79-95</Citation><ArticleIdList><ArticleId IdType="pubmed">8879138</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1981 Jul;78(7):4170-4</Citation><ArticleIdList><ArticleId IdType="pubmed">6945577</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 1985 Nov;4(11):3021-4</Citation><ArticleIdList><ArticleId IdType="pubmed">4065098</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1980 Mar;141(3):362-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7365284</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6785-90</Citation><ArticleIdList><ArticleId IdType="pubmed">10823895</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 1989 Dec;7(6):557-61</Citation><ArticleIdList><ArticleId IdType="pubmed">2609730</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1994 Mar;68(3):1551-63</Citation><ArticleIdList><ArticleId IdType="pubmed">7508997</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1989 Nov;63(11):4603-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2795713</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1991 Jul;183(1):32-43</Citation><ArticleIdList><ArticleId IdType="pubmed">2053285</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2000 Nov;74(22):10807-10</Citation><ArticleIdList><ArticleId IdType="pubmed">11044127</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1980 Feb;33(2):583-6</Citation><ArticleIdList><ArticleId IdType="pubmed">6893343</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1990 Nov;179(1):51-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2219738</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull Hist Med. 1991 Spring;65(1):4-21</Citation><ArticleIdList><ArticleId IdType="pubmed">2021692</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1996 Oct;70(10):6653-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8794300</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1991 Feb;180(2):617-24</Citation><ArticleIdList><ArticleId IdType="pubmed">1989386</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Mar;69(3):1964-70</Citation><ArticleIdList><ArticleId IdType="pubmed">7853543</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1994 Jan;75 ( Pt 1):37-42</Citation><ArticleIdList><ArticleId IdType="pubmed">8113738</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1981 Mar;53(Pt 1):125-32</Citation><ArticleIdList><ArticleId IdType="pubmed">7276909</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Diagn. 1997 Sep;2(3):217-230</Citation><ArticleIdList><ArticleId IdType="pubmed">10462613</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1998 Sep 15;249(1):52-61</Citation><ArticleIdList><ArticleId IdType="pubmed">9740776</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Genes. 1997;14(3):187-94</Citation><ArticleIdList><ArticleId IdType="pubmed">9311563</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1994 Dec;68(12):8141-6</Citation><ArticleIdList><ArticleId IdType="pubmed">7966605</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1980 Nov;36(2):586-90</Citation><ArticleIdList><ArticleId IdType="pubmed">7431489</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1992 May 1;69(3):517-28</Citation><ArticleIdList><ArticleId IdType="pubmed">1374685</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2001 Jul;75(13):6154-65</Citation><ArticleIdList><ArticleId IdType="pubmed">11390617</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1985 Mar;40(3):627-33</Citation><ArticleIdList><ArticleId IdType="pubmed">3882238</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1980 May 10;8(9):1965-74</Citation><ArticleIdList><ArticleId IdType="pubmed">6927841</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 1992 Sep 1;25(1-2):37-50</Citation><ArticleIdList><ArticleId IdType="pubmed">1413993</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Virol. 2000 Oct;44(5):241-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11252668</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1997 Mar 21;275(5307):1793-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9065404</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Feb;69(2):1219-25</Citation><ArticleIdList><ArticleId IdType="pubmed">7529332</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2000 Dec;74(24):11538-47</Citation><ArticleIdList><ArticleId IdType="pubmed">11090151</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2000 Feb;74(4):1781-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10644350</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1999 Feb 1;254(1):196-209</Citation><ArticleIdList><ArticleId IdType="pubmed">9927586</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1994 Feb;68(2):911-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7507186</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1977 Mar 21;237(12):1225-8</Citation><ArticleIdList><ArticleId IdType="pubmed">576459</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1988 May;62(5):1508-12</Citation><ArticleIdList><ArticleId IdType="pubmed">3282079</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2000 Sep;74(18):8709-19</Citation><ArticleIdList><ArticleId IdType="pubmed">10954572</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1989 Sep;63(9):3586-94</Citation><ArticleIdList><ArticleId IdType="pubmed">2474671</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1981 Oct;40(1):323-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7288926</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1994 Jan;68(1):530-4</Citation><ArticleIdList><ArticleId IdType="pubmed">8254767</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1979 Jan;42(1):189-91</Citation><ArticleIdList><ArticleId IdType="pubmed">759556</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1999 Sep;73(9):7467-73</Citation><ArticleIdList><ArticleId IdType="pubmed">10438836</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2746-51</Citation><ArticleIdList><ArticleId IdType="pubmed">11226311</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6883-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11371620</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1992 Jan;186(1):294-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1727605</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Virol. 1993;133(3-4):283-94</Citation><ArticleIdList><ArticleId IdType="pubmed">8257290</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2001 Oct 10;289(1):34-44</Citation><ArticleIdList><ArticleId IdType="pubmed">11601915</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1651-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9990079</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1997 Jul;78 ( Pt 7):1589-96</Citation><ArticleIdList><ArticleId IdType="pubmed">9225034</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1994 Nov 15;205(1):133-40</Citation><ArticleIdList><ArticleId IdType="pubmed">7526533</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1992 May 15;69(4):577-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1375129</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Fanning, Thomas G" sort="Fanning, Thomas G" uniqKey="Fanning T" first="Thomas G" last="Fanning">Thomas G. Fanning</name><name sortKey="Janczewski, Thomas A" sort="Janczewski, Thomas A" uniqKey="Janczewski T" first="Thomas A" last="Janczewski">Thomas A. Janczewski</name><name sortKey="Mccall, Sherman" sort="Mccall, Sherman" uniqKey="Mccall S" first="Sherman" last="Mccall">Sherman Mccall</name><name sortKey="Taubenberger, Jeffery K" sort="Taubenberger, Jeffery K" uniqKey="Taubenberger J" first="Jeffery K" last="Taubenberger">Jeffery K. Taubenberger</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Reid, Ann H" sort="Reid, Ann H" uniqKey="Reid A" first="Ann H" last="Reid">Ann H. Reid</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000653 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000653 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:12368314
|texte= Characterization of the 1918 "Spanish" influenza virus matrix gene segment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:12368314" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |